These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20876413)

  • 1. Risk refinement, reclassification, and treatment thresholds in primary prevention of cardiovascular disease: incremental progress but significant gaps remain.
    O'Malley PG; Redberg RF
    Arch Intern Med; 2010 Sep; 170(17):1602-3. PubMed ID: 20876413
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients.
    Budoff MJ; Shaw LJ; Liu ST; Weinstein SR; Mosler TP; Tseng PH; Flores FR; Callister TQ; Raggi P; Berman DS
    J Am Coll Cardiol; 2007 May; 49(18):1860-70. PubMed ID: 17481445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of multifactorial prevention of cardiovascular diseases on lifetime prognosis: ten-year follow-up].
    Kalinina AM; Chazova LV
    Ter Arkh; 1998; 70(1):8-12. PubMed ID: 9532642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CUORE: a sustainable cardiovascular disease prevention strategy.
    Giampaoli S
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):161-2. PubMed ID: 17446792
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin for primary prevention of cardiovascular events in people with diabetes.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
    [No Abstract]   [Full Text] [Related]  

  • 6. Coronary calcification improves cardiovascular risk prediction in the elderly.
    Vliegenthart R; Oudkerk M; Hofman A; Oei HH; van Dijck W; van Rooij FJ; Witteman JC
    Circulation; 2005 Jul; 112(4):572-7. PubMed ID: 16009800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of low risk and higher risk profiles in middle age to frequency and quantity of coronary artery calcium years later.
    Daviglus ML; Pirzada A; Liu K; Yan LL; Garside DB; Dyer AR; Hoff JA; Kondos GT; Greenland P; Stamler J
    Am J Cardiol; 2004 Aug; 94(3):367-9. PubMed ID: 15276108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery calcification and myocardial perfusion: kissing cousins or distant relatives?
    Vogel RA
    J Am Coll Cardiol; 2006 Sep; 48(5):1027-8. PubMed ID: 16949497
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening programs for individuals at risk of cardiovascular disease.
    Rybicki FJ; Gerson DS; Bettmann M; Yucel EK
    Am J Cardiol; 2007 May; 99(10):1481-2. PubMed ID: 17493487
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of high sensitivity C-reactive protein in coronary artery disease risk prediction: a review.
    Abou Diwan CH; Oghlakian GO; Antonios SI; Otrock ZK; Rebeiz AG
    J Med Liban; 2004; 52(1):39-47. PubMed ID: 15881701
    [No Abstract]   [Full Text] [Related]  

  • 11. Stratification for noninvasive coronary angiography: patient preselection considering atypical angina pectoris, conventional cardiovascular risk assessment, and calcium scoring.
    Langer C; Wiemer M; Peterschröder A; Franzke K; Mellwig KP; van Buuren F; Koester-Eiserfunke W; Butz T; Diekmann J; Horstkotte D
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):201-9. PubMed ID: 19305353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estimate of cardiovascular risk. Theory, tools and problems.
    Menotti A; Puddu PE; Lanti M
    Ann Ital Med Int; 2002; 17(2):81-94. PubMed ID: 12150050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin overprescription in primary cardiovascular prevention.
    Manes C; Giacci L; Sciartilli A; D'Alleva A; De Caterina R
    Thromb Res; 2006; 118(4):471-7. PubMed ID: 16321425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. It's your heart.
    Tecnologica; 1999 Oct; ():1, 3-6, 15. PubMed ID: 10848080
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
    Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
    Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and prevention of cardiovascular diseases].
    Jánosi A
    Orv Hetil; 2005 Apr; 146(15):683-8. PubMed ID: 15895792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disordered lipid metabolism--current diagnostics].
    Schwandt P
    MMW Fortschr Med; 2003 Mar; 145(13):26-7. PubMed ID: 15101528
    [No Abstract]   [Full Text] [Related]  

  • 19. [Integration of a new risk marker into cardiovascular prevention, using coronary calcium as an example].
    Möhlenkamp S; Lehmann N; Moebus S; Schmermund A; Jöckel KH; Erbel R;
    Dtsch Med Wochenschr; 2009 Oct; 134(40):2023-6. PubMed ID: 19777421
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.